Risk assessment of gastric cancer and Helicobacter pylori may vary depending upon the antibody used;: Anti-CagA specific antibody versus commercial available anti-H-pylori antibody

被引：0
|
作者：
Maeda, S [1 ]
Ogura, K [1 ]
Yoshida, H [1 ]
Yamaji, Y [1 ]
Mitsuno, Y [1 ]
Akanuma, Y [1 ]
Shiratori, Y [1 ]
Omata, M [1 ]
机构：
[1] Univ Tokyo, Tokyo, Japan
来源：
GUT | 1999年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A45 / A46
页数：2
相关论文
共 48 条
  • [31] Feasibility of cutoff value measured by supersensitive serum anti-Helicobacter pylori antibody titer in gastric cancer screening program
    Gotoda, Takuji
    Kusano, Chika
    Suzuki, Sho
    Ishikawa, Hideki
    Moriyama, Mitsuhiko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 78 - 79
  • [32] A prospective study of gastric cancer development by endoscopic follow up; Risk ratio assessment by serum pepsinogen and anti Helicobacter pylori antibody status in 6993 Japanese subjects
    Watabe, H
    Togo, G
    Yamaji, Y
    Okamoto, M
    Yoshida, H
    Kawabe, T
    Wada, R
    Mitsushima, T
    Omata, M
    GASTROENTEROLOGY, 2003, 124 (04) : A56 - A56
  • [33] Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan
    Saito, Shota
    Azumi, Motoi
    Muneoka, Yusuke
    Nishino, Katsuhiko
    Ishikawa, Takashi
    Sato, Yuichi
    Terai, Shuji
    Akazawa, Kouhei
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (04): : 545 - 555
  • [34] Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan
    Shota Saito
    Motoi Azumi
    Yusuke Muneoka
    Katsuhiko Nishino
    Takashi Ishikawa
    Yuichi Sato
    Shuji Terai
    Kouhei Akazawa
    The European Journal of Health Economics, 2018, 19 : 545 - 555
  • [35] Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer
    Camargo, M. Constanza
    Kim, Kyoung-Mee
    Matsuo, Keitaro
    Torres, Javier
    Liao, Linda M.
    Morgan, Douglas R.
    Michel, Angelika
    Waterboer, Tim
    Zabaleta, Jovanny
    Dominguez, Ricardo L.
    Yatabe, Yasushi
    Kim, Sung
    Rocha-Guevara, Erick R.
    Lissowska, Jolanta
    Pawlita, Michael
    Rabkin, Charles S.
    HELICOBACTER, 2016, 21 (02) : 153 - 157
  • [36] Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels - The ABC Method
    Yamaguchi, Yasuharu
    Nagata, Yasuhiko
    Hiratsuka, Ryuuta
    Kawase, Yoshihiko
    Tominaga, Tatsurou
    Takeuchi, Shunji
    Sakaganni, Shinya
    Ishida, Shusei
    DIGESTION, 2016, 93 (01) : 13 - 18
  • [37] Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels in the Northwestern Tokyo Area
    Yamaguchi, Yasuharu
    Nagata, Yasuhiko
    Hiratsuka, Ryuuta
    Tominaga, Tatsuro
    Kawase, Yoshihiko
    Takeuchi, Shunji
    Ishida, Shusei
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S1033 - S1034
  • [38] Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-"ABC method"
    Miki, Kazumasa
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2011, 87 (07): : 405 - 414
  • [39] Usefulness of a New Gastric Cancer Screening Program Using the Combination Assay of Serum Anti-Helicobacter pylori IgG Antibody and the Serum Pepsinogen Levels
    Kodashima, Shinya
    Miki, Kazumasa
    Fujishiro, Mitsuhiro
    Yahagi, Naohisa
    Koike, Kazuhiko
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S38 - S38
  • [40] Evaluation of gastric cancer screening using a serum pepsinogen level or an anti-Helicobacter pylori antibody, compared with endoscopic findings as criterion standard.
    Ikuma, H
    Mitsushima, T
    Nagatani, K
    GASTROENTEROLOGY, 1998, 114 (04) : A614 - A614
12345